The expression of 11β-HSDs, GR, and H6PDH in subcutaneous adipose tissue from polycystic ovary syndrome subjects

Hormone and Metabolic Research

Volumn 45, Issue 11, 2013, Pages 802-807

  Li, S ^a   Tao, T ^a   Wang, L ^a   Mao, X ^a   Zheng, J ^a   Zhao, A ^a   Liu, W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

11 hydroxysteroid dehydrogenase (11 HSD) type 1 and 2; adipocytokine; adipose tissue; glucocorticoids receptor(GR); hexose 6 phosphate dehydrogenase (H6PDH); polycystic ovary syndrome (PCOS)

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ADIPOCYTOKINE; ADIPONECTIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADIPOKINES; ADULT; ANTHROPOMETRY; CARBOHYDRATE DEHYDROGENASES; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; POLYCYSTIC OVARY SYNDROME; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84885960572     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1345186     Document Type: Article

References (47)

1. Franks S. Polycystic ovary syndrome. N Engl J Med: 1995; 333 853 861
2. Tao T., Li S., Zhao A., Mao X., Liu W. Early impaired β-cell function in chinese women with polycystic ovary syndrome. Int J Clin Exp Pathol: 2012; 5 777 786
3. Wang L., Li S., Zhao A., Tao T., Mao X., Zhang P., Liu W. The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients. J Steroid Biochem Mol Biol: 2012; 132 120 126
4. Tao T., Li S., Zhao A., Zhang Y., Liu W. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol: 2012; 167 705 713
5. Bujalska I. J., Walker E. A., Hewison M., Stewart P. M. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab: 2002; 87 1205 1210 (Pubitemid 36121089)
6. Bujalska I. J., Kumar S., Hewison M., Stewart P. M. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology: 1999; 140 3188 3196 (Pubitemid 30650636)
7. Jamieson P. M., Chapman K. E., Edwards C. R., Seckl J. R. 11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology: 1995; 136 4754 4761 (Pubitemid 3002167)
8. Stulnig T. M., Waldhäusl W. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes. Diabetologia: 2004; 47 1 11 (Pubitemid 38141933)
9. McCormick K. L., Wang X., Mick G. J. Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes. J Biol Chem: 2006; 281 341 347 (Pubitemid 43671194)
10. Masuzaki H., Paterson J., Shinyama H., Morton N. M., Mullins J. J., Seckl J. R., Flier J. S. A transgenic model of visceral obesity and the metabolic syndrome. Science: 2001; 294 2166 2170 (Pubitemid 33150673)
11. Morton N. M., Holmes M. C., Fiévet C., Staels B., Tailleux A., Mullins J. J., Seckl J. R. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem: 2001; 276 41293 41300
12. Morton N. M., Paterson J. M., Masuzaki H., Holmes M. C., Staels B., Fievet C., Walker B. R., Flier J. S., Mullins J. J., Seckl J. R. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes: 2004; 53 931 938 (Pubitemid 38436604)
13. Rask E., Walker B. R., Söderberg S., Livingstone D. E., Eliasson M., Johnson O., Andrew R., Olsson T. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab: 2002; 87 3330 3336 (Pubitemid 34816385)
14. Andrews R. C., Rooyackers O., Walker B. R. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab: 2003; 88 285 291 (Pubitemid 36115179)
15. Sandeep T. C., Andrew R., Homer N. Z., Andrews R. C., Smith K., Walker B. R. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes: 2005; 54 872 879 (Pubitemid 40322093)
16. Slieker L. J., Sloop K. W., Surface P. L., Kriauciunas A., LaQuier F., Manetta J., Bue-Valleskey J., Stephens T. W. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem: 1996; 271 5301 5304 (Pubitemid 26083858)
17. Vidal-Puig A. J., Considine R. V., Jimenez-Liñan M., Werman A., Pories W. J., Caro J. F., Flier J. S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest: 1997; 99 2416 2422 (Pubitemid 27227719)
18. Boullu-Ciocca S., Paulmyer-Lacroix O., Fina F., Ouafik L., Alessi M. C., Oliver C., Grino M. Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obes Res: 2003; 11 925 929 (Pubitemid 41137502)
19. Seckl J. R., Walker B. R. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology: 2001; 142 1371 1376 (Pubitemid 32299662)
20. Bujalska I. J., Kumar S., Stewart P. M. Does central obesity reflect "Cushing's disease of the omentumo"? Lancet: 1997; 349 1210 1213 (Pubitemid 27190044)
21. Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. N Engl J Med: 1994; 330 460 465 (Pubitemid 24058934)
22. Gambineri A., Vicennati V., Genghini S., Tomassoni F., Pagotto U., Pasquali R., Walker B. R. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab: 2006; 91 2295 2302 (Pubitemid 43855020)
23. San Millán J. L., Botella-Carretero J. I., Alvarez-Blasco F., Luque-Ramírez M., Sancho J., Moghetti P., Escobar-Morreale H. F. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab: 2005; 90 4157 4162 (Pubitemid 41058191)
24. Zawadzki J. K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J. R., Haseltine F. P., Merriam G. R. (eds.). Polycystic Ovary Syndrome. Boston Blackwell Scientific Publications: 1992; 377 384
25. Vermeulen A., Verdonck L., Kaufman J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab: 1999; 84 3666 3672 (Pubitemid 30645223)
26. Svendsen P. F., Madsbad S., Nilas L., Paulsen S. K., Pedersen S. B. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome. Int J Obes (Lond): 2009; 33 1249 1256
27. Wake D. J., Homer N. Z., Andrew R., Walker B. R. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab: 2006; 91 4682 4688 (Pubitemid 44833457)
28. Westerbacka J., Cornér A., Kannisto K., Kolak M., Makkonen J., Korsheninnikova E., Nyman T., Hamsten A., Fisher R. M., Yki-Järvinen H. Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia: 2006; 49 132 140 (Pubitemid 43151624)
29. Balachandran A., Guan H., Sellan M., van Uum S., Yang K. Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology: 2008; 149 4069 4079
30. Zhu L., Hou M., Sun B., Burén J., Zhang L., Yi J., Hernell O., Li X. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children. J Clin Endocrinol Metab: 2010; 95 3300 3308
31. Mattsson C., Rask E., Carlström K., Andersson J., Eliasson M., Ahrén B., Söderberg S., Olsson T. Gender-specific links between hepatic 11beta reduction of cortisone and adipokines. Obesity (Silver Spring): 2007; 15 887 894 (Pubitemid 46740964)
32. Li X., Lindquist S., Chen R., Myrnäs T., Angsten G., Olsson T., Hernell O. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int J Obes (Lond): 2007; 31 820 828 (Pubitemid 46663808)
33. Williams L. J., Lyons V., MacLeod I., Rajan V., Darlington G. J., Poli V., Seckl J. R., Chapman K. E. C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J Biol Chem: 2000; 275 30232 30239
34. Escher G., Galli I., Vishwanath B. S., Frey B. M., Frey F. J. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J Exp Med: 1997; 186 189 198 (Pubitemid 27328019)
35. Friedberg M., Zoumakis E., Hiroi N., Bader T., Chrousos G. P., Hochberg Z. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. J Clin Endocrinol Metab: 2003; 88 385 393 (Pubitemid 36115193)
36. Ignatova I. D., Kostadinova R. M., Goldring C. E., Nawrocki A. R., Frey F. J., Frey B. M. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab: 2009; 296 E367 E377
37. Lindsay R. S., Wake D. J., Nair S., Bunt J., Livingstone D. E., Permana P. A., Tataranni P. A., Walker B. R. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab: 2003; 88 2738 2744 (Pubitemid 36724450)
38. Livingstone D. E., Jones G. C., Smith K., Jamieson P. M., Andrew R., Kenyon C. J., Walker B. R. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology: 2000; 141 560 563 (Pubitemid 32250479)
39. Paulmyer-Lacroix O., Boullu S., Oliver C., Alessi M. C., Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab: 2002; 87 2701 2705 (Pubitemid 34655333)
40. Rask E., Olsson T., Söderberg S., Andrew R., Livingstone D. E., Johnson O., Walker B. R. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab: 2001; 86 1418 1421 (Pubitemid 32323037)
41. Stewart P. M., Boulton A., Kumar S., Clark P. M., Shackleton C. H. Cortisol metabolism in human obesity: impaired cortisone->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab: 1999; 84 1022 1027 (Pubitemid 29138237)
42. Wake D. J., Rask E., Livingstone D. E., Söderberg S., Olsson T., Walker B. R. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab: 2003; 88 3983 3988 (Pubitemid 37034555)
43. Goedecke J. H., Wake D. J., Levitt N. S., Lambert E. V., Collins M. R., Morton N. M., Andrew R., Seckl J. R., Walker B. R. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf): 2006; 65 81 87
44. Veilleux A., Laberge P. Y., Morency J., Noël S., Luu-The V., Tchernof A. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. J Steroid Biochem Mol Biol: 2010; 122 28 34
45. Tomlinson J. W., Sinha B., Bujalska I., Hewison M., Stewart P. M. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab: 2002; 87 5630 5635 (Pubitemid 36034370)
46. Tomlinson J. W., Finney J., Gay C., Hughes B. A., Hughes S. V., Stewart P. M. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity. Diabetes: 2008; 57 2652 2660
47. Paulsen S. K., Nielsen M. P., Richelsen B., Bruun J. M., Flyvbjerg A., Pedersen S. B. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring): 2008; 16 731 735 (Pubitemid 351465625)